CommercialCoverageMedium impact
05.00.84, Apos® biomechanical shoe system
Independence Blue Cross·Orthopedics, PM&R (Physical Medicine & Rehab), Podiatry +1 more·Pharmacy
Effective date
Dec 10, 2025
We identified it
Jun 19, 2026
Summary
IBX Commercial has reissued policy 05.00.84 regarding the Apos® biomechanical shoe system, a specialized footwear device categorized under pharmacy benefits. This is a policy reissue effective December 10, 2025, though the specific content changes are not detailed in the summary provided.
Action Required
By December 10, 2025: Billing team should review the complete reissued policy 05.00.84 for Apos® biomechanical shoe systems on the IBX provider portal to identify any changes in coverage criteria, billing requirements, or prior authorization processes. Update billing procedures and encounter forms accordingly for any IBX Commercial members requiring this specialized footwear.